CN Patent
CN119837892A — 局部用组合物
Assigned to Bausch Health Ireland Ltd · Expires 2025-04-18 · 1y expired
What this patent protects
本发明提供了局部用凝胶制剂,其包含1‑1.5%重量的克林霉素磷酸酯、2.5‑3.5%重量的过氧化苯甲酰和0.1‑0.2%重量的阿达帕林,以及胶凝剂、多元醇和水,用于治疗包括痤疮在内的炎症性皮肤病,以及其制备和使用方法。
USPTO Abstract
本发明提供了局部用凝胶制剂,其包含1‑1.5%重量的克林霉素磷酸酯、2.5‑3.5%重量的过氧化苯甲酰和0.1‑0.2%重量的阿达帕林,以及胶凝剂、多元醇和水,用于治疗包括痤疮在内的炎症性皮肤病,以及其制备和使用方法。
Drugs covered by this patent
- Differin (ADAPALENE) · Galderma Labs Lp
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.